Pollogen (Lumenis) Geneo X
Hydradermabrasion · OxyGeneo 3-in-1 (Glo2Facial)
The Pollogen (Lumenis) Geneo X typically sells new in the $30k–$40k range in the US. Pollogen (Lumenis) Geneo X holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: TriPollar RF applicator cleared for mild-to-moderate facial wrinkles (Fitzpatrick I-IV); OxyGeneo applicator cleared only as massage
Last verified: August 6, 2026 · How we verify
New: $30k–$40k|Used: —market estimate, no email required
| Manufacturer | Pollogen (Lumenis) |
|---|---|
| Company | Owner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct |
| Category | Facial & Wellness |
| Technology | OxyGeneo 3-in-1 (Glo2Facial) |
| FDA status | FDA Cleared |
| New price range | $30k–$40k |
| Used price range | Not published |
| Consumables | Not published |
| Launch year | 2022 |
| Last verified | August 6, 2026 |
Bottom line
The best-packaged "facial franchise in a box" in the category — Lumenis marketing muscle, a consumer-facing Glo2Facial brand, and three modalities (OxyGeneo exfoliation/oxygenation, TriPollar RF, ultrasound) that let you sell a $250 facial with a straight face. The catch: you're marrying a pod ecosystem — every treatment burns branded OxyPods and gel, and the machine is deliberately useless without them. At a realistic $25-35k all-in it pays back fast in a busy room, but it is not cheaper to own than a HydraFacial — same razor-blade math, better branding. Buy it if you'll push memberships; skip it if pods sitting in a drawer will haunt you.
Overview
Current Glo2Facial platform
How it works
The science
The OxyGeneo step grinds an effervescent OxyPod against the skin in nutrient gel, creating a CO2-rich microenvironment at the surface; the body responds by shunting oxygenated blood to the area (the Bohr effect) — plausible physiology, modest clinical evidence. Mechanically: gentle chemical-mechanical exfoliation plus infusion of pod actives (retinol, vitamin C, azelaic/mandelic acids by flavor). The TriPollar handpiece adds focused RF for dermal heating and short-term tightening; ultrasound drives product penetration and the "lymphatic massage" finish. Net: brighter, plumper, temporarily tighter skin with zero downtime — a maintenance treatment, not a corrective one.
Patented tech
OxyGeneo is the patented pod-plus-gel effervescence system (originally Pollogen's Capsugen); TriPollar is Pollogen's long-standing focused RF — both real proprietary tech predating the Glo2Facial rebrand, which is pure consumer branding.
Origin
Israel (Pollogen, Lumenis' facial arm since 2017).
FDA & regulatory status
What it's actually cleared for:
TriPollar RF applicator cleared for mild-to-moderate facial wrinkles (Fitzpatrick I-IV); OxyGeneo applicator cleared only as massage
510(k) numbers
K233766
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Pollogen (Lumenis) that can affect warranty, service and parts availability.
- Sep 2021
Boston Scientific acquires Lumenis surgical unit for $1.07B
DivestitureBoston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.
Source: Boston Scientific and BPEA press releases
Treatment economics
What practices charge
$150-300 per Glo2Facial ($200-250 sweet spot), "signature" versions bundling RF and ultrasound at the top. Memberships $129-199/month are the standard play; six OxyPod flavors give built-in seasonal upsells; neck/decollete add-ons $50-100.
Consumables & recurring cost
$15-25 per treatment in pods and gel kits through Lumenis — and you cannot run the treatment without them. 40 treatments/month ≈ $7-12k/year; kits have expiration dates, so overbuying "deal" bundles is a classic rookie loss.
Ideal for
Best-fit practice
Medspas and high-end day spas selling facial memberships that want a branded no-downtime flagship an aesthetician runs back-to-back in 30-45 minutes. Skews 25-55, all Fitzpatrick types, event-driven and maintenance-minded — the same client who'd book a HydraFacial. Weak fit for clinical practices wanting corrective outcomes.
Compliance
Medical director & delegation
OxyGeneo/ultrasound steps are aesthetician territory essentially everywhere; the TriPollar RF step is where a handful of states require delegation or a medical director. Most buyers run the full protocol under a standard medspa MD arrangement.
Contraindications & screening
Pregnancy, active acne pustules/rosacea flares, open lesions, allergies to pod actives; the RF step adds metal implants, pacemakers, and recent filler/toxin timing. Standard exfoliation cautions for isotretinoin or fresh peels/laser.
Ownership
Warranty & service
1-year standard through Lumenis with extended plans sold hard at closing; depot/swap-based service, generally responsive because Lumenis wants the pod revenue flowing.
Resale & used market
Used Geneo/Geneo X at $8-18k depending on generation — but buyers must verify Lumenis will still sell them pods; an orphaned unit is a doorstop. Expect 40-60% depreciation in three years.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
Head-to-head comparisons buyers ask for
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.